☰

Grunenthal

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of Grunenthal's published strategy and is not endorsed by, or produced in cooperation with, Grunenthal. Company website

Strategic priorities

Grunenthal operates across 4 stated priorities, with the most concrete near-term plan anchored on ebitda-accretive growth.

Bridging patent-expiry revenue gaps through targeted acquisitions worth EUR 2.1 billion since 2017, including Movantik, Qutenza, and regional Cialis rights.

Pivoting R&D focus from traditional opioids to NOP receptor agonists, NaV channel blockers, and other innovative pain therapies to lead the non-opioid pain management market.

Expanding and modernizing manufacturing network across Germany, Switzerland, Italy, Chile, and Ecuador to ensure reliable supply to 100+ countries while meeting strict serialization requirements.

Challenges we see

  • Operations Manufacturing

    Technology Transfer Risk for Cialis Manufacturing

    The acquisition of regional Cialis rights from Eli Lilly requires moving production to the Santiago, Chile facility over the next several years, representing a high-stakes technology transfer for Mexico, Brazil, and Colombia markets.

    If the transfer relies on paper-based SOPs or fragmented data records, time-to-market will be delayed, impacting acquisition ROI and therapeutic equivalence validation.

  • Digital Integration

    Multi-Speed Digital Network Asymmetry

    New EUR 80 million Latin American facilities have modern hardware but legacy European sites like Mitlodi and Origgio handle record production volumes with potentially older machinery and fragmented data collection.

    Data visibility is high in some regions and opaque in others, creating "multi-speed" network where global operations intelligence is incomplete and maintenance debt accumulates at high-volume legacy sites.

  • Digital R&D

    Phase III Clinical Trial Failures

    Two Phase III studies for resiniferatoxin (RTX) did not meet primary endpoints in 2024, highlighting gaps in utilizing R&D data for predictive analysis of clinical outcomes.

    Without digital twins and predictive simulations of biological processes, expensive wet-lab experiments proceed to clinical stage without adequate de-risking, leading to costly late-stage failures.

  • Digital Security

    IT/OT Cybersecurity Exposure

    The 2024/25 annual report identifies increasing cyberattack risk due to reliance on cloud services and mobile devices, with the IT/OT intersection being the most vulnerable point.

    Without durable IT/OT convergence — VLAN segmentation and containerized architectures — the 2.2 billion tablet production line in Origgio could be left open to enterprise-level threats.

  • ESG Compliance

    Scope 3 Emissions Data Lag

    The Responsibility Report admits Scope 3 emissions data lags by one year due to timely data availability issues, relying on spend-based scaling rather than direct supplier data integration.

    Current manual step estimation methodology is insufficient under new European Sustainability Reporting Standards (ESRS), risking compliance gaps and stakeholder trust erosion.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Fragmented Technology Transfer Documentation

    Moving Cialis production from Eli Lilly to Santiago requires absolute process alignment, but the transfer may rely on paper-based SOPs and fragmented data records that risk knowledge loss and regulatory delays.

    Deploy a Digital Twin framework for manufacturing processes that captures process parameters, equipment configurations, and validation data in a unified platform enabling smooth technology transfer execution.

  2. Legacy Site Maintenance Debt

    European sites like Mitlodi (33% of world tramadol) and Origgio (2.2 billion tablets/year) operate at record volumes with potentially older machinery, creating maintenance debt and limited windows for digital upgrades.

    Implement non-invasive industrial automation using external sensors and AI vision systems to monitor critical process parameters without interrupting GxP-validated processes or requiring production shutdowns.

  3. R&D Data Silos and Predictive Modeling Gaps

    R&D units in Boston and Aachen produce vast amounts of dark data not easily accessible to manufacturing teams, leading to Phase III failures like resiniferatoxin and inefficiencies during scale-up.

    Build a unified Digital Lab platform that connects R&D data with manufacturing intelligence, enabling predictive modeling and digital twin simulations to de-risk clinical programs before expensive late-stage trials.

  4. CDMO Transparency and Customer Visibility

    Grunenthal PRO manages 53% of production volume for external customers, but the high complexity of managing both generics and innovative treatments makes it difficult to provide real-time batch progress and quality metrics.

    Deploy an Industrial Data Platform that unifies manufacturing data across all sites, providing CDMO customers with real-time transparency into batch progress, quality metrics, and supply chain status.

  5. Manual ESG Data Collection and Reporting

    Scope 3 emissions data lags by one year because of manual spend-based scaling and spend-to-weight ratio calculations rather than direct, real-time data integration with suppliers.

    Implement an automated Scope 3 data pipeline that integrates directly with supplier systems, replacing manual estimation with real-time data capture to meet ESRS requirements and SBTi validation needs.

What we'd propose

  • Digital Lab

    Digital Twin for Technology Transfer Excellence

    A comprehensive digital replica of manufacturing processes that captures all parameters, equipment configurations, and validation protocols to enable smooth technology transfers between sites and reduce time-to-market for acquired products.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Non-Invasive Industrial Monitoring Retrofit

    Deploy external sensor arrays and AI vision systems to monitor legacy high-volume production lines without interrupting GxP-validated processes, enabling predictive maintenance and real-time process intelligence at the Mitlodi and Origgio sites.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    TechBio R&D Data Platform

    Build a unified data ecosystem that connects R&D laboratories in Boston and Aachen with manufacturing intelligence, enabling predictive modeling and digital simulations to de-risk drug development programs before clinical trials.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    IT/OT Cybersecurity Shield

    Implement a comprehensive IT/OT convergence framework that protects manufacturing assets through network segmentation, containerized architectures, and zero-trust security principles while enabling secure data flow for digital transformation initiatives.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI
  • Enterprise AI

    Automated ESG Data Pipeline

    Deploy an Industrial Data Platform that automates Scope 3 emissions data collection from suppliers, replacing manual spend-based calculations with real-time data integration to achieve ESRS compliance and support carbon neutrality goals.

    • Ontology layer

      A shared semantic model so lab, process, and quality data describe the same things the same way.

      DETAIL

    • Predictive models

      Models trained on the historical data plane that flag deviations before they become scrap.

      DETAIL

    • Decision surfaces

      Single pane of glass that surfaces model output to the right role at the right moment.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Enterprise AI

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what Grunenthal's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Data Integration 45 → 85
Multi-speed network with data visibility gaps between new Latin American sites and legacy European facilities; R&D dark data disconnected from manufacturing
Process Automation 55 → 90
Paper-based processes persist in production despite digital roadmap; manual interventions still common in high-volume lines
Predictive Analytics 35 → 80
Phase III failures indicate gaps in predictive modeling; retrospective analysis dominates over real-time process intelligence
Cybersecurity Posture 50 → 85
Identified cloud and mobile device risks; IT/OT convergence strategies lacking; vulnerable to lateral movement attacks
ESG Data Maturity 40 → 85
Scope 3 data lags one year; spend-based estimation insufficient for ESRS; manual supplier data collection
Technology Transfer Readiness 45 → 90
Massive Cialis transfer pending; fragmented documentation risks; need for digital process replication capabilities

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with Grunenthal, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].